Sanigen Co

Sanigen Co EBITDA per Share

The EBITDA per Share of Sanigen Co (188260.KQ) as of Nov 2, 2026 is -801.28 KRW. In the previous year, EBITDA per Share was -629.21 KRW — a change of 27.35% (lower).

EBITDA per Share

-801.28KRW

YoY

27.35%

Last updated:

EBITDA per Share of Sanigen Co is 2025 -801.28 KRW. EBITDA per Share of Sanigen Co was 2024 -629.21 KRW. It decreases by 27.35% lower compared to the previous year.

The Sanigen Co EBITDA per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBITDA per Share
Date
EBITDA per Share
Jan 1, 2019
-72.50 KRW
Jan 1, 2020
-249.42 KRW
Jan 1, 2022
-520.18 KRW
Jan 1, 2023
-1,192.83 KRW
Jan 1, 2024
-629.21 KRW
Jan 1, 2025
-801.28 KRW
The Sanigen Co EBITDA per Share history
YEAREBITDA per ShareYoY
-801.28KRW+27.35%
-629.21KRW-47.25%
-1,192.83KRW+129.31%
-520.18KRW+108.56%
-249.42KRW+244.02%
-72.50KRW—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Sanigen Co Stock analysis

What does Sanigen Co do? Sanigen Co Ltd generates revenue through the manufacturing and sale of food safety diagnostic products, utilizing advanced molecular diagnostic technologies including polymerase chain reaction (PCR) and next-generation sequencing (NGS). The company provides food microbial genome analysis services as part of its offerings. Its primary customers are entities requiring food safety testing, such as food manufacturers and regulatory agencies. The firm operates within the Health Care Equipment & Supplies industry, focusing on diagnostic solutions for food safety. Sanigen Co Ltd's product portfolio includes diagnostic products developed using PCR and NGS technologies, which are sold to clients in the food safety sector. The company's services encompass microbial genome analysis, targeting clients needing detailed food safety assessments. The business model centers on delivering diagnostic tools and services that ensure food safety through advanced molecular technologies. The company's revenue streams are derived from the sale of diagnostic products and the provision of microbial genome analysis services. These offerings are tailored to meet the needs of food safety testing in the industry. Sanigen Co Ltd's focus on molecular diagnostic technologies positions it as a provider of specialized solutions within the health care equipment and supplies market. Sanigen Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Sanigen Co stock

EBITDA per Share of Sanigen Co is -801.28 KRW in 2025.

EBITDA per Share of Sanigen Co changed from -629.21 KRW to -801.28 KRW, representing a 27.35% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EBITDA per Share Sanigen Co since 2006 – with annual values, charts, and detailed analysis.

EBITDA per share divides EBITDA by shares outstanding, showing the operating cash earnings allocated to each share before depreciation and financing effects.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Income Statement — Sanigen Co

All Key Metrics — Sanigen Co